Breast Imaging Technologies Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, Japan, China - Size and Forecast 2024-2028

Breast Imaging Technologies Market Size 2024-2028

The breast imaging technologies market size is forecast to increase by USD 2.23 billion, at a CAGR of 8.51% between 2023 and 2028.

• The market is experiencing significant growth, driven by the increasing emphasis on early diagnosis and preventive medicine. This trend is fueled by the rising awareness of breast cancer and the advancements in imaging technologies, enabling earlier and more accurate detection. Additionally, the market is witnessing a growing focus on courses and medical exhibitions for breast imaging products, providing opportunities for industry players to showcase their innovations and build relationships with healthcare professionals. However, the market faces challenges, including the lack of knowledge and low adoption of Advanced Breast Ultrasound Systems (ABUS). Despite their potential benefits, such as improved accuracy in dense breast tissue and reducing false positives, many healthcare providers remain unfamiliar with the technology.
• This presents an opportunity for companies to invest in education and training programs, addressing the knowledge gap and increasing the adoption of ABUS in breast imaging practices. By capitalizing on the market's growth drivers and navigating the challenges effectively, companies can position themselves for success in the dynamic and evolving breast imaging technologies landscape.

What will be the Size of the Breast Imaging Technologies Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2018-2022 and forecasts 2024-2028 - in the full report.
Request Free Sample

The market continues to evolve, driven by advancements in technology and growing demand for early and accurate diagnosis. Image-guided biopsy techniques, such as vacuum-assisted and stereotactic, play a crucial role in enhancing diagnostic accuracy. Quality assurance and image processing are integral components of these technologies, ensuring regulatory compliance and maintaining diagnostic consistency. CE marking and image analysis enable remote diagnosis, expanding access to care and improving efficiency. Biopsy needles and image interpretation are essential elements of the diagnostic process, with ongoing research focusing on reducing radiation dose and improving patient safety. Regulatory compliance and radiation protection are paramount, with regulatory bodies continually updating guidelines.

Deep learning and artificial intelligence (AI) are increasingly being integrated into breast imaging, enhancing diagnostic accuracy and streamlining workflows. Magnetic resonance imaging (MRI) and computer-aided detection are complementary technologies, providing additional diagnostic insights and reducing false positives. Preventive screening and early detection remain key priorities, with ongoing clinical trials exploring new contrast agents and image acquisition techniques. Ultrasound-guided biopsy and MRI-guided biopsy offer alternatives to traditional needle biopsy, expanding diagnostic options and improving patient comfort. Image compression, data storage, and workflow optimization are essential for managing the large volumes of data generated by these advanced technologies.

Ongoing research and innovation continue to shape the market, with a focus on improving diagnostic accuracy, reducing radiation dose, and enhancing patient safety. The integration of AI and deep learning is expected to significantly impact the market, enabling more efficient and accurate diagnosis.

How is this Breast Imaging Technologies Industry segmented?

The breast imaging technologies industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

• Type
  • Mammography
  • Breast ultrasound
  • Breast MRI
  • Image-guided breast biopsy
  • Other imaging techniques
• Geography
  • North America
    • US
  • Europe
    • Germany
    • UK
  • APAC
    • China
    • Japan
  • Rest of World (ROW)

By Type Insights

The mammography segment is estimated to witness significant growth during the forecast period.

The market is experiencing significant growth due to the increasing emphasis on early detection of breast cancer. The United States Preventive Services Task Force and similar organizations have established guidelines for mammography screenings, driving demand in this segment. The rising geriatric population and escalating prevalence of breast cancer, which was the most common cancer diagnosis in 2023 with approximately 297,790 invasive and 55,720 non-invasive cases, further fuel market expansion. Advanced technologies like machine learning, computer-aided detection, and artificial intelligence (AI) are revolutionizing breast imaging, enabling remote diagnosis and improving diagnostic accuracy. Image-guided biopsies, including vacuum-assisted, stereotactic, core needle, and MRI-guided, offer enhanced precision and patient safety.

Regulatory compliance, quality assurance, and quality control are crucial factors, with FDA approval and CE marking ensuring standardization. Image processing, analysis, and reconstruction technologies optimize workflows, reduce false positives and negatives, and enhance diagnostic accuracy. Radiation protection and image compression are essential considerations to minimize patient discomfort and streamline data storage. Clinical trials and contrast-enhanced mammography (CEM) contribute to the development of innovative breast imaging technologies.

Request Free Sample

The Mammography segment was valued at USD 1.6 billion in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

North America is estimated to contribute 40% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

Request Free Sample

The market in North America is currently leading the global landscape, driven by the rising prevalence of breast cancer, increased focus on early detection, and growing investment in advanced diagnostic tools. This market's expansion is further fueled by initiatives from government and private entities, such as cancer-specialized hospitals, clinics, and diagnostic centers. The American Cancer Society and the Radiological Society of North America recommend regular mammograms and breast examinations for women over 40, making North America an attractive market for breast imaging technologies. Advancements in machine learning, computer-aided detection, and artificial intelligence (AI) are revolutionizing breast imaging, enabling remote diagnosis and improving diagnostic accuracy.

Image-guided biopsies, including vacuum-assisted, stereotactic, and core needle biopsies, are increasingly utilized for precise and minimally invasive procedures. Regulatory compliance, quality assurance, and patient safety are paramount, with FDA approval and CE marking ensuring the safety and efficacy of these technologies. Breast ultrasound and magnetic resonance imaging (MRI) are essential alternatives for women with dense breasts or those who cannot undergo mammography due to radiation concerns. Contrast agents and image processing techniques enhance image quality and diagnostic accuracy. Workflow optimization and image interpretation are crucial for efficient and effective breast cancer screening. Clinical trials and research are ongoing to further refine these technologies, with a focus on reducing false positives and false negatives, improving patient comfort, and minimizing radiation doses.

Data storage and image reconstruction technologies enable efficient handling and analysis of large volumes of data, contributing to early detection and improved patient outcomes.

Market Dynamics

Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

What are the key market drivers leading to the rise in the adoption of Breast Imaging Technologies Industry?

• Focusing on early diagnosis and preventive medicine is essential for market growth. By prioritizing these areas, we can effectively address health concerns before they become more serious and costly to manage. This approach not only benefits individuals by improving their overall well-being but also contributes to reducing healthcare expenditures and enhancing the sustainability of the healthcare industry.

• The demand for breast imaging technologies has surged due to increasing health consciousness among individuals. Early diagnosis of breast-related conditions, such as tumors and breast cancer, through advanced imaging techniques like ultrasound, has become crucial for effective treatment and disease management. These technologies enable healthcare professionals to assess patient conditions accurately, leading to improved patient outcomes. Proper diagnosis is vital for determining the best course of treatment and ensuring timely intervention. As a result, the market for breast imaging technologies is experiencing significant growth, driven by the importance of early detection and diagnosis in healthcare. The integration of data storage solutions with these technologies further enhances their utility, enabling healthcare providers to maintain comprehensive patient records and facilitate efficient diagnosis and treatment planning.
• The use of advanced imaging technologies, combined with improved lifestyle habits and treatment methods, can significantly reduce the incidence and impact of chronic diseases related to the breast.

What are the market trends shaping the Breast Imaging Technologies Industry?

• The increasing importance of breast imaging courses and medical exhibitions represents a significant market trend. This focus on education and product showcases signifies a commitment to advancing breast imaging technology and techniques.

• Breast imaging technologies play a crucial role in the early detection and diagnosis of breast cancer. One significant factor influencing this market is the increasing awareness of breast density and its association with breast cancer risk. To address this, advanced imaging technologies such as breast ultrasound and machine learning algorithms are being employed for remote diagnosis, particularly in cases of dense breast tissue. These technologies enable more accurate diagnosis and reduce the need for unnecessary biopsies. Another trend in the market is the integration of computer-aided detection (CAD) systems and image-guided biopsy techniques. CAD systems use artificial intelligence to identify potential breast abnormalities, while image-guided biopsy techniques, such as needle biopsy, facilitate more precise and less invasive breast biopsies.
• However, radiation dose from mammography remains a concern, leading to the increasing popularity of ultrasound and other non-ionizing imaging techniques. The Food and Drug Administration (FDA) has approved several new breast imaging technologies in recent years, further driving market growth. Overall, the market is expected to continue growing due to increasing demand for early and accurate breast cancer diagnosis.

What challenges does the Breast Imaging Technologies Industry face during its growth?

• The insufficient understanding and limited implementation of Advanced Bonding and Underwriting Systems (ABUS) represent significant challenges impeding industry expansion.

• The market is witnessing significant growth due to the rising prevalence of breast cancer and the increasing emphasis on early detection. Companies are developing advanced breast imaging devices, such as vacuum-assisted biopsy (VAC) systems and stereotactic biopsy systems, to improve diagnostic accuracy. While VAC systems offer tissue sampling with less invasiveness, stereotactic biopsy ensures precise targeting of the lesion. Quality assurance and regulatory compliance are crucial aspects of breast imaging technologies. Image processing and analysis play a vital role in enhancing the diagnostic accuracy of these systems. CE marking and regulatory approvals, such as FDA clearance, are essential for market entry and customer trust.
• Deep learning algorithms are increasingly being integrated into breast imaging systems to improve image analysis and detection capabilities. Magnetic resonance imaging (MRI) is another advanced technology used for breast imaging, offering high soft tissue contrast and excellent spatial resolution. However, the use of these advanced technologies requires extensive training for clinicians to understand their operational aspects and optimally utilize them for breast cancer diagnosis. Stereotactic biopsy systems, for instance, need precise positioning of the biopsy needle to ensure accurate tissue sampling. Proper training and quality assurance measures are necessary to ensure the effective use of these systems and maintain the highest standards of patient care.

Exclusive Customer Landscape

The breast imaging technologies market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the breast imaging technologies market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

Customer Landscape

Key Companies & Market Insights

Companies are implementing various strategies, such as strategic alliances, breast imaging technologies market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.

AURORA HEALTHCARE US Corp. - The Aurora 1.5T Dedicated Breast MRI System from an unspecified provider delivers advanced 3-D bilateral breast imaging, enabling clinicians and their patients to benefit from superior breast cancer detection, diagnosis, and biopsy capabilities.

The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

• AURORA HEALTHCARE US Corp.
• Canon Inc.
• CMR Naviscan Corp.
• Delphinus Medical Technologies Inc.
• Dilon Medical Technologies Inc.
• FUJIFILM Corp.
• General Electric Co.
• General Medical Merate Spa
• Hologic Inc.
• Koning Corp.
• Koninklijke Philips N.V.
• MEDI-FUTURE Inc.
• Metaltronica Spa
• Micrima Ltd.
• Perlong Medical Equipment Co. Ltd.
• Shenzhen Anke High tech Co.
• Siemens AG
• Sino Medical Device Technology Co. Ltd.
• SonoCine Inc.
• Tualatin Imaging PC

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Recent Development and News in Breast Imaging Technologies Market

• In January 2024, GE Healthcare launched its new digital mammography system, Senographe Pristina, featuring advanced image processing technology and a user-friendly design, as per their official press release. This innovation aimed to enhance breast cancer detection and improve patient comfort.
• In March 2024, Philips and IBM Watson Health announced a strategic collaboration to integrate IBM Watson's AI capabilities into Philips' mammography systems. This partnership aimed to improve diagnostic accuracy and efficiency, as stated in Philips' press release.
• In May 2024, Siemens Healthineers raised €1.2 billion in a funding round, as reported by Reuters. The funds were intended to support the company's growth in digitalization and artificial intelligence in healthcare, including breast imaging technologies.
• In April 2025, the U.S. Food and Drug Administration (FDA) approved Hologic's Genius AI 3D Mammography System, as per the company's press release. This approval marked the first AI-assisted 3D mammography system in the U.S. Market, which is expected to significantly improve breast cancer detection.

Research Analyst Overview

• The market is witnessing significant advancements in various areas, including mass detection, lesion characterization, and risk stratification. Clinical decision support systems are increasingly being integrated into imaging workflows to aid in diagnosis and treatment planning. In surgical oncology, image registration and oncoplastic surgery are enabling more precise tumor localization and improved cosmetic outcomes. Follow-up care is being enhanced through quantitative imaging techniques, such as shear wave elastography and gene expression profiling, for breast density assessment and biomarker detection. Digital mammography remains the gold standard for breast cancer screening, but 3D imaging and microcalcification detection are gaining popularity for their ability to provide more detailed information.
• Image fusion and segmentation are also key technologies enabling more accurate diagnosis and treatment planning. Radiation oncology is benefiting from advances in elasticity imaging and biomarker detection for personalized treatment plans. Patient education is a critical component of breast cancer care, and imaging technologies are playing an essential role in facilitating better communication between patients and healthcare providers.

Dive into Technavio's robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Breast Imaging Technologies Market insights. See full methodology.

Request Free Sample

What are the Key Data Covered in this Breast Imaging Technologies Market Research and Growth Report?

• CAGR of the Breast Imaging Technologies industry during the forecast period
• Detailed information on factors that will drive the growth and forecasting between 2024 and 2028
• Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
• Accurate predictions about upcoming growth and trends and changes in consumer behaviour
• Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
• Thorough analysis of the market's competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the breast imaging technologies market growth of industry companies

We can help! Our analysts can customize this breast imaging technologies market research report to meet your requirements.

Get in touch